{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T04:24:18Z","timestamp":1743913458238},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,10,17]]},"DOI":"10.18632\/oncotarget.20177","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T17:01:48Z","timestamp":1502470908000},"page":"85479-85491","source":"Crossref","is-referenced-by-count":3,"title":["PAX3d mRNA over 2.76 copies\/\u00b5L in the bloodstream predicts cutaneous malignant melanoma relapse"],"prefix":"10.18632","volume":"8","author":[{"given":"Chiara","family":"Autilio","sequence":"first","affiliation":[{"name":"Institute of Clinical Biochemistry, Laboratory of Clinical Molecular Diagnostics, Fondazione Policlinico \u201cA. Gemelli\u201d, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Paolillo","sequence":"additional","affiliation":[{"name":"Institute of Clinical Biochemistry, Laboratory of Clinical Molecular Diagnostics, Fondazione Policlinico \u201cA. Gemelli\u201d, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Michela","family":"Lavieri","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, \u201cCristo Re\u201d Hospital, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krizia","family":"Pocino","sequence":"additional","affiliation":[{"name":"Institute of Clinical Biochemistry, Laboratory of Clinical Molecular Diagnostics, Fondazione Policlinico \u201cA. Gemelli\u201d, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"De Paolis","sequence":"additional","affiliation":[{"name":"Institute of Clinical Biochemistry, Laboratory of Clinical Molecular Diagnostics, Fondazione Policlinico \u201cA. Gemelli\u201d, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Di Stasio","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry, Fondazione Policlinico \u201cA. Gemelli\u201d, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Sant\u2019Andrea Hospital, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cappellini Antonini","family":"Gian Carlo","sequence":"additional","affiliation":[{"name":"Oncology Unit Immacolata Dermatological Institute (IDI), Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ettore","family":"Capoluongo","sequence":"additional","affiliation":[{"name":"Institute of Clinical Biochemistry, Laboratory of Clinical Molecular Diagnostics, Fondazione Policlinico \u201cA. Gemelli\u201d, Catholic University of the Sacred Heart, Rome, Italy"},{"name":"Laboratory of Advanced Molecular Diagnostics (DIMA), Istituto Dermopatico dell\u2019Immacolata, Fondazione Luigi Maria Monti, IRCCS, Rome, Italy"},{"name":"\u201cMolipharma Srl\u201d a Spinoff of Catholic University, Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/pcmr.12041","article-title":"Emerging molecular targets in melanoma invasion and metastasis","volume":"26","author":"Sanz-Moreno","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy","volume":"445","author":"Marais","year":"2007","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Mihm","year":"2006","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Gimotty","year":"2009","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/pcmr.12544","article-title":"Metastatic pathways in patients with cutaneous melanoma","volume":"30","author":"Mar","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1586\/14737159.3.3.303","article-title":"Biomarkers in melanoma: staging, prognosis and detection of early metastases","volume":"3","author":"Ross","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrc3820","article-title":"Challenges in circulating tumour cell research","volume":"14","author":"Pantel","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ijc.28436","article-title":"Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma","volume":"134","author":"Stern","year":"2014","journal-title":"Int J Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/jid.2012.468","article-title":"Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma","volume":"133","author":"Dive","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1158\/1078-0432.CCR-10-0037","article-title":"Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma","volume":"16","author":"Richards","year":"2010","journal-title":"Clin Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"42008","DOI":"10.18632\/oncotarget.5788","article-title":"Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma","volume":"6","author":"Cooper","year":"2015","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7150\/thno.5195","article-title":"Detecting circulating tumor cells: current challenges and new trends","volume":"3","author":"Zu","year":"2013","journal-title":"Theranostics"},{"key":"13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cca.2015.02.013","article-title":"Absolute quantitative PCR for detection of molecular biomarkers in melanoma patients: a preliminary report","volume":"444","author":"Capoluongo","year":"2015","journal-title":"Clin Chim Acta"},{"key":"14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1755-148X.2012.01025.x","article-title":"Melanoma revives an embryonic migration program to promote plasticity and invasion","volume":"25","author":"Kulesa","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"15","first-page":"229","article-title":"MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a \u201cGenetic Switch\u201d Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma","volume":"3","author":"Baguley","year":"2013","journal-title":"Front Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00002371-200501000-00002","article-title":"Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE)","volume":"28","author":"Kawakami","year":"2005","journal-title":"J Immunother"},{"key":"17","unstructured":"Mort, Jackson, Patton. The melanocyte lineage in development and disease. Development."},{"key":"18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(93)90429-T","article-title":"Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein","volume":"74","author":"Arnheiter","year":"1993","journal-title":"Cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1038\/sj.onc.1206443","article-title":"Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival","volume":"22","author":"Fisher DE","year":"2003","journal-title":"Oncogene"},{"key":"20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Flavell","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"21","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/S0959-804930484-7","article-title":"Prediction of numbers of melanoma deaths by 2050","volume":"72","author":"Boniol","year":"2017","journal-title":"Eur J Cancer"},{"key":"22","article-title":"Cancer Facts and figures 2017","author":"American Cancer Society","year":"2017","journal-title":"Gen"},{"key":"23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ncponc1296","article-title":"Melanoma biomarkers: current status and vision for the future","volume":"6","author":"Alani","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/pcmr.12172","article-title":"Why is melanoma so metastatic?","volume":"27","author":"Bar-Eli","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)63110-0","article-title":"Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study","volume":"164","author":"Rodr\u00edguez-Peralto","year":"2004","journal-title":"Am J Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome","volume":"98","author":"Sarasin","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.0303-6987.2004.00243.x","article-title":"Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship","volume":"31","author":"Carlson","year":"2004","journal-title":"J Cutan Pathol"},{"key":"28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.283.4.479","article-title":"Prognostic value of pololike kinase expression in melanomas","volume":"283","author":"Kaufmann","year":"2000","journal-title":"JAMA"},{"key":"29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved Survival with Ipilimumab in Patients with Metastatic Melanoma","volume":"363","author":"Lutzky","year":"2010","journal-title":"N Engl J Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib","volume":"366","author":"Lawrence","year":"2012","journal-title":"N Engl J Med"},{"key":"31","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-06-3481","article-title":"A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis","volume":"67","author":"Artiga","year":"2007","journal-title":"Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.200601018","article-title":"The epithelial-mesenchymal transition: new insights in signaling, development, and disease","volume":"172","author":"Thompson","year":"2006","journal-title":"J Cell Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.molmed.2006.01.006","article-title":"Circulating tumor cells: the \u2018leukemic phase of solid cancers","volume":"12","author":"Nitti","year":"2006","journal-title":"Trends Mol Med"},{"key":"34","first-page":"823","article-title":"PAX3 is expressed in human melanomas and contributes to tumor cell survival","volume":"61","author":"Sch\u00e4fer","year":"2001","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/1535-7163.MCT-04-0252","article-title":"Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity","volume":"4","author":"Eccles","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(93)90429-T","article-title":"Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein","volume":"74","author":"Arnheiter","year":"1993","journal-title":"Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1600-0749.2002.01080.x","article-title":"Identification of a distal enhancer for the melanocyte-specific promoter of the MITF gene","volume":"15","author":"Shibahara","year":"2002","journal-title":"Pigment Cell Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molcel.2008.11.002","article-title":"Inhibition of PAX3 by TGF-beta modulates melanocyte viability","volume":"32","author":"Cui","year":"2008","journal-title":"Mol Cell"},{"key":"39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1755-148X.2009.00541.x","article-title":"How TGF-beta and PAX3 Regulate Suntanning","volume":"22","author":"Loeken","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"40","first-page":"1887","article-title":"Melanoma-associated expression of transforming growth factor-beta isoforms","volume":"148","author":"Elder","year":"1996","journal-title":"Am J Pathol"},{"key":"41","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1038\/srep17319","article-title":"Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol","volume":"5","author":"Govorun","year":"2015","journal-title":"Sci Rep"},{"key":"42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/bjd.12057","article-title":"Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression","volume":"168","author":"Ziman","year":"2013","journal-title":"Br J Dermatol"},{"key":"43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CMR.0b013e328341c7e0","article-title":"PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression","volume":"21","author":"Eccles","year":"2011","journal-title":"Melanoma Res"},{"key":"44","doi-asserted-by":"crossref","first-page":"e8461","DOI":"10.1371\/journal.pone.0008461","article-title":"A gene expression signature of invasive potential in metastatic melanoma cells","volume":"4","author":"Eccles","year":"2009","journal-title":"PLoS One"},{"key":"45","first-page":"1","article-title":"MITF Expression in Cutaneous Malignant Melanoma","volume":"3","author":"Eaker-Falt","year":"2012","journal-title":"J Mol Biomark Diagn"},{"key":"46","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness","volume":"20","author":"Goding","year":"2006","journal-title":"Genes Dev"},{"key":"47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1755-148X.2011.00849.x","article-title":"Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor","volume":"24","author":"Hayward","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"48","doi-asserted-by":"crossref","first-page":"e40476","DOI":"10.1371\/journal.pone.0040476","article-title":"Molecular characterization of circulating tumor cells in human metastatic colorectal cancer","volume":"7","author":"L\u00f3pez-L\u00f3pez","year":"2012","journal-title":"PLoS One"},{"key":"49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cccn.2005.05.031","article-title":"Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers","volume":"362","author":"Capoluongo","year":"2005","journal-title":"Clin Chim Acta"},{"key":"50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ab.2008.05.024","article-title":"The normalization of gene expression data in melanoma: investigating the use of glyceraldehyde 3-phosphate dehydrogenase and 18S ribosomal RNA as internal reference genes for quantitative real-time PCR","volume":"380","author":"Fields","year":"2008","journal-title":"Anal Biochem"},{"key":"51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"Clarke-Pearson","year":"1988","journal-title":"Biometrics"},{"key":"52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-59745-530-5_14","article-title":"Logistic regression","volume":"404","author":"Campbell","year":"2007","journal-title":"Methods Mol Biol"},{"key":"53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Meier","year":"1958","journal-title":"Journal of the American Statistical Association"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T17:07:45Z","timestamp":1596733665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":53,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2017,10,17]]}},"alternative-id":["20177","29156734"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20177","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]}}}